TABLE 2.
SARS‐CoV‐2 IgG positive | SARS‐CoV‐2 IgG negative | SARS‐CoV‐2 IgG not reported a | All patients | |||||
---|---|---|---|---|---|---|---|---|
No. | (%) | No. | (%) | No. | (%) | No. | (%) | |
Number of unique patients | 20 | (6.2) | 237 | (73.8) | 64 | (19.9) | 321 | (100) |
History of symptoms | 6 | (30.0) | 24 | (10.1) | 5 | (7.8) | 35 | (10.9) |
Asymptomatic | 13 | (65.0) | 184 | (77.6) | 28 | (43.8) | 225 | (70.1) |
Symptoms not recorded | 1 | (5.0) | 29 | (12.2) | 30 | (48.4) | 61 | (19.0) |
Known exposure | 7 | (35.0) | 12 | (5.1) | 1 | (1.6) | 20 | (6.2) |
No known exposure | 12 | (60.0) | 141 | (59.5) | 18 | (28.1) | 171 | (53.3) |
Exposure not recorded | 1 | (5.0) | 84 | (35.4) | 44 | (70.3) | 130 | (40.5) |
Extended family member death due to COVID‐19 b | 1 | (5.0) | 5 | (2.1) | 0 | (0.0) | 6 | (1.9) |
Sixty‐four patients did not have COVID‐19 antibodies drawn due to unordered by provider (n = 35), lab cancellation (n = 15), no indicated screening labs (n = 12), local labs not performed by patient (n = 1), or labs hemolyzed (n = 1).
Family member deaths included grandparent (n = 5) and aunt (n = 1).
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.